Relay Therapeutics Inc.
RLAY | NASDAQ
$18.75
+$0.56 (+3.08%)
Sep 22, 2026, 2:39 PM ET · Market open
Market Data
Market Cap $3.99B
Enterprise Value $3.9B
Beta 1.70
Average Volume 3.49M
Shares Outstanding (Diluted) 202.85M
Shares Change YoY 18.44%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US75943R1023
Price Performance
Price Change 1M -5.1%
Price Change 3M 4.3%
Price Change 6M 89.5%
Price Change YTD 122.4%
Price Change 1Y 300.7%
Price Change 3Y 111.0%
Price Change 5Y -50.5%
1M CAGR (ann.) -8.0%
1Y CAGR (ann.) 299.8%
5Y CAGR (ann.) -12.6%
All-Time CAGR -10.1%
Valuation
PE Ratio -11.59
Forward PE N/A
PEG Ratio -0.52
Forward PEG -15.94
PS Ratio 385.14
Forward PS 222.60
PB Ratio 4.48
P/FCF Ratio -15.14
P/Adj. FCF Ratio -12.37
P/OCF Ratio -17.32
EV/Sales 376.39
EV/EBIT -13.62
EV/EBITDA -13.58
EV/FCF -14.79
Earnings Yield -8.6%
FCF Yield -6.6%
Adj. FCF Yield -8.1%
Financial Health
Net Cash $90.53M
Total Debt $30.66M
Cash & Short-Term Investments $121.19M
Total Assets $967.46M
Current Ratio 18.27
Quick Ratio 18.27
Debt / Equity Ratio 0.03
Debt / EBITDA -0.11
Debt / FCF -0.12
OCF / Debt -8.59
Interest Coverage 0.00
Altman Z-Score 27.86
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin -566.6%
Operating Profit Margin -2999.4%
EBITDA Margin -2771.8%
Net Profit Margin -2763.6%
FCF Margin -2544.1%
Adj. FCF Margin -3112.7%
SBC / Revenue 466.8%
SBC Impact (per share) -22.4%
Returns
Return on Assets -29.6%
Return on Equity -42.3%
Return on Invested Capital -33.7%
Return on Capital Employed -33.9%
Return on Tangible Assets -29.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 122.3%
Revenue CAGR 5Y -34.3%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 23.8%
EPS CAGR 5Y 11.6%
EPS CAGR 10Y N/A
FCF CAGR 3Y 3.7%
FCF CAGR 5Y -4.3%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 15
EPS Growth Next 3Y 8.1%
Revenue Growth Next 3Y 150.3%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.40
EPS Growth Est (next Q) -7.0%
Revenue Est (next Q) $1.62M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $26.25
Price Target Upside 44.3%
Cash Flow
Operating Cash Flow $-263.32M
Free Cash Flow $-263.32M
Adj. Free Cash Flow $-322.16M
FCF Per Share -$1.05
OCF Per Share -$1.05
OCF/S Ratio -2050.3%
Income Statement
Revenue $10.35M
Gross Profit $-58.64M
Operating Income $-310.44M
EBITDA $-286.88M
Net Income $-286.04M
EPS (Diluted) -$1.57
Revenue / Employee $51.24K
Profit / Employee $-1.42M
Employees 202
Add to Watchlist
Select watchlists to add or remove RLAY